Luminal A versus luminal B breast cancer: MammaTyper mRNA versus immunohistochemical subtyping with an emphasis on standardised Ki67 labelling‐based or mitotic activity index‐based proliferation assessment-Reference-Cited by-同舟云学术

Luminal A versus luminal B breast cancer: MammaTyper mRNA versus immunohistochemical subtyping with an emphasis on standardised Ki67 labelling‐based or mitotic activity index‐based proliferation assessment

Published:2020-03-24 Issue:5 Volume:76 Page:650-660
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Finsterbusch Kai¹,Decker Thomas¹,Diest Paul J²,Focke Cornelia M¹²^ORCID

Affiliation:

1. Department of Surgical Pathology Dietrich Bonhoeffer Medical Centre Neubrandenburg Germany

2. Department of Pathology University Medical Centre Utrecht Utrecht The Netherlands

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14048

Reference39 articles.

1. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

2. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

3. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

4. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

5. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head‐to‐head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?;Histopathology;2024-05-10

2. Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer;Frontiers in Endocrinology;2024-03-18

3. Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study;Breast Cancer Research and Treatment;2024-03-07

4. Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study;2023-12-20

5. Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis;Annals of Translational Medicine;2022-12